Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Aurinia Pharmaceuticals revenue
Aurinia Pharmaceuticals's revenue is $235.1 million.
What is Aurinia Pharmaceuticals's revenue?
- Aurinia Pharmaceuticals's revenue growth from 2019 to 2024 is 73,841.19%.
- Aurinia Pharmaceuticals has 33 employees, and the revenue per employee ratio is $7,125,242.
- Aurinia Pharmaceuticals's peak quarterly revenue was $67.8M in 2024(q3).
- Aurinia Pharmaceuticals peak revenue was $235.1M in 2024.
- Aurinia Pharmaceuticals annual revenue for 2023 was 175.5M, 30.95% growth from 2022.
- Aurinia Pharmaceuticals annual revenue for 2024 was 235.1M, 33.97% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Aurinia Pharmaceuticals historical revenue
Aurinia Pharmaceuticals annual revenue
Aurinia Pharmaceuticals annual revenue over time
| Fiscal year / year | Aurinia Pharmaceuticals revenue |
|---|---|
| 2019 | $318,000 |
| 2020 | $50.1M |
| 2021 | $45.6M |
| 2022 | $134.0M |
| 2023 | $175.5M |
| 2024 | $235.1M |
How accurately did Aurinia Pharmaceuticals' revenue projections match actual performance?
Aurinia Pharmaceuticals annual growth
Aurinia Pharmaceuticals annual growth rate over time
| Year | Aurinia Pharmaceuticals growth |
|---|---|
| 2020 | 15660%↑ |
| 2021 | -9%↓ |
| 2022 | 194%↑ |
| 2023 | 31%↑ |
| 2024 | 34%↑ |
Aurinia Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Aurinia Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | - | $50.1M |
| 2021 | $914,000 | $6.6M | $14.7M | $23.4M |
| 2022 | $21.6M | $28.2M | $55.8M | $28.4M |
| 2023 | $34.4M | $41.5M | $54.5M | $45.1M |
| 2024 | $50.3M | $57.2M | $67.8M | $59.9M |
Aurinia Pharmaceuticals jobs nearby
Do you work at Aurinia Pharmaceuticals?
Is Aurinia Pharmaceuticals transparent about its revenue structure?
Aurinia Pharmaceuticals financial information
| CEO | Mr. Stephen Zaruby W. |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 33 |
| Date Founded | 2013 |
| Number of Locations | 2 |
| Revenue | $235.1M |
| Gross Proft | $206.9M (2024) |
| EBITDA | ($89.8M) (2019) |
| PE Ratio | 82.95 |
| Tax Rate | 0.2% |
| Market Capitalization | $477.1M |
| Ticker | AUPH |
Aurinia Pharmaceuticals jobs you might like
Aurinia Pharmaceuticals financing
Aurinia Pharmaceuticals received early financing of $4.7M on 2013-09-23.
| Series | Round size | Date |
|---|---|---|
| Post Ipo Equity | $4.7M | 09/2013 |
| Post Ipo Equity | $52M | 02/2014 |
| Post Ipo Equity | $7M | 06/2016 |
| Post Ipo Equity | $28.8M | 12/2016 |
| Post Ipo Equity | $173.1M | 03/2017 |
| Post Ipo Equity | $191.7M | 12/2019 |
| Post Ipo Equity | $200M | 07/2020 |
Aurinia Pharmaceuticals investors
| Investors | Security type |
|---|---|
| Difference Capital | Post Ipo Equity |
| Lumira Ventures | Post Ipo Equity |
| ILJIN Life Science | Post Ipo Equity |
| Redmile Group | Post Ipo Equity |
| Difference Capital | Post Ipo Equity |
| Apple Tree Partners | Post Ipo Equity |
| Lumira Ventures | Post Ipo Equity |
| New Enterprise Associates (NEA) | Post Ipo Equity |
| Great Point Partners | Post Ipo Equity |
| venBio Partners | Post Ipo Equity |
| RA Capital Management | Post Ipo Equity |
| ILJIN Life Science | Post Ipo Equity |
Aurinia Pharmaceuticals revenue FAQs
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Aurinia Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Aurinia Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Aurinia Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Aurinia Pharmaceuticals. The data presented on this page does not represent the view of Aurinia Pharmaceuticals and its employees or that of Zippia.
Aurinia Pharmaceuticals may also be known as or be related to AURINIA PHARMACEUTICALS INC., Aurinia Pharmaceuticals, Aurinia Pharmaceuticals Inc, Aurinia Pharmaceuticals Inc. and Aurinia Pharmaceuticals, Inc.